Expression and function of miR-155 in breast cancer

被引:14
|
作者
Liu, Jing [1 ]
Huang, WenHui [1 ]
Yang, HaiXia [2 ]
Luo, Ying [1 ]
机构
[1] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China
[2] Municipal Author Clin Jinan, Outpatient Dept, Jinan, Shandong, Peoples R China
关键词
miR-155; breast cancer; oncogenic miRNA; target genes; TRANSCRIPTION FACTOR FOXO3A; CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; MICRORNAS; GROWTH; METASTASIS; NETWORKS; PATHWAY;
D O I
10.1080/13102818.2015.1043946
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A major problem in the treatment of breast cancer at present is the lack of more sensitive and specific tumour biomarkers. MicroRNAs (miRNAs) were first discovered as important regulators of development in Caenorhabditis elegans, and their functions have been widely investigated. miR-155 is an oncogenic miRNA which has been explored mainly in leukaemia but is also known to play an important role in the progression of breast cancer. There is an accumulating body of evidence about additional roles of miR-155 in the development of breast cancer. In this mini-review, we provide an overview and update of miR-155 expression and its roles in breast cancer. We also attempt to summarize the current understanding of miR-155 regulation networks and speculate on the potential of miR-155 as a putative accessory parameter for diagnosis of breast cancer.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [1] Role of miR-155 in breast cancer
    Wang, Jie
    Wu, Jianhua
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 : 2350 - 2355
  • [2] Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients
    Liu, Jingjing
    Mao, Qixin
    Liu, Yan
    Hao, Xiaomeng
    Zhang, Sheng
    Zhang, Jin
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 46 - 54
  • [3] Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis
    Zheng, Shu-Rong
    Guo, Gui-Long
    Zhang, Wei
    Huang, Guan-Li
    Hu, Xiao-Qu
    Zhu, Jin
    Huang, Qi-Di
    You, Jie
    Zhang, Xiao-Hua
    ONCOLOGY REPORTS, 2012, 27 (04) : 1149 - 1155
  • [4] Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
    Grimaldi, Anna Maria
    Nuzzo, Silvia
    Condorelli, Gerolama
    Salvatore, Marco
    Incoronato, Mariarosaria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 13
  • [5] Expression profile of miR-155 and miR-34a in peripheral blood and tissues of breast cancer patients
    Tan, Xiaolang
    Guo, Lei
    Luo, Shayang
    Wang, Weiming
    Zhang, Kejing
    Chen, Feiyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7566 - 7570
  • [6] Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients
    Jingjing Liu
    Qixin Mao
    Yan Liu
    Xiaomeng Hao
    Sheng Zhang
    Jin Zhang
    ChineseJournalofCancerResearch, 2013, 25 (01) : 46 - 54
  • [7] Role of miR-155 in drug resistance of breast cancer
    Yu, Dan-dan
    Lv, Meng-meng
    Chen, Wei-xian
    Zhong, Shan-liang
    Zhang, Xiao-hui
    Chen, Lin
    Ma, Teng-fei
    Tang, Jin-hai
    Zhao, Jian-hua
    TUMOR BIOLOGY, 2015, 36 (03) : 1395 - 1401
  • [8] Up-regulated expression of miR-155 in human colonic cancer
    Cao, Hongliang
    Huang, Shaojun
    Liu, Aihua
    Chen, Zhidan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (03) : 604 - 607
  • [9] The Oncogenic Role of miR-155 in Breast Cancer
    Mattiske, Sam
    Suetani, Rachel J.
    Neilsen, Paul M.
    Callen, David F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) : 1236 - 1243
  • [10] Diagnostic value of circulating miR-155, miR-21, and miR-10b as promising biomarkers in human breast cancer
    Zhang, Jingquan
    Jiang, Cen
    Shi, Xinming
    Yu, Hua
    Lin, Han
    Peng, Yibing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10258 - 10265